$2500 | Single User
$5000 | Site License
$7500 | Enterprise License

Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015
[Published by Global Data]

Published by Global Data: 04 Dec 2015 | 17668 | In Stock
Related Topics: Clinical Trials

Introduction

Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015" provides an overview of Vaginal Atrophy (Atrophic Vaginitis) clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginal Atrophy (Atrophic Vaginitis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Vaginal Atrophy (Atrophic Vaginitis) to Women's Health Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Vaginal Atrophy (Atrophic Vaginitis) to Women's Health Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials 28

    Prominent Drugs 30

    Clinical Trial Profile Snapshots 31

    Appendix 76

    Abbreviations 76

    Definitions 76

    Research Methodology 77

    Secondary Research 77

    About GlobalData 78

    Contact Us 78

    Disclaimer 78

    Source 78

List Of Tables
in Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Tables

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials by Region, 2015* 6

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Vaginal Atrophy (Atrophic Vaginitis) to Women's Health Clinical Trials, G7 Countries (%), 2015* 15

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Vaginal Atrophy (Atrophic Vaginitis) to Women's Health Clinical Trials, E7 Countries (%), 2015* 18

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List Of Figures, Charts and Diagrams
in Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Figures

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13

Proportion of Vaginal Atrophy (Atrophic Vaginitis) to Women's Health Clinical Trials, G7 Countries (%), 2015* 15

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Vaginal Atrophy (Atrophic Vaginitis) to Women's Health Clinical Trials, E7 Countries (%), 2015* 18

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Vaginal Atrophy (Atrophic Vaginitis) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 77

Additional Details

Publisher

Global Data

Publisher Information

Reference

17668 | GDHC3031CTIDB

Number of Pages

78

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2017
Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest...
13 Jun 2017 by Global Markets Direct USD $2,000 More Info
Vaginal Cancer - Pipeline Review, H1 2017
Vaginal Cancer - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and He...
13 Jun 2017 by Global Markets Direct USD $2,000 More Info
Global Vaginal Laxity Market: Size, Trends & Forecasts (2017-2021)
Scope of the ReportThe report titled “Global Vaginal Laxity Market: Size, Trends & Forecasts (2017-2...
01 Jun 2017 by Daedal Research USD $800 More Info
Gynecological Devices Market: By Endoscope Types (Colposcopies, Laparoscopes, Resect scopes); By Devices (Vaginal Speculum, Examination Chairs, Cervical Dilators, Ablation and Fluid Management Devices and Others); By End Users (Hospitals, Clinics/ASCs, Research Institutes) & Geography Forecast (2017-2022)
Gynecological devices are extensively used in hospitals, clinics/ASCs, research institutes and diagn...
05 May 2017 by USD $5,250 More Info
Topical Drug Delivery Market by Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research) - Global Forecast to 2021
The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40...
27 Mar 2017 by MarketsandMarkets USD $5,650 More Info
Vaginal Cancer Global Clinical Trials Review, H1, 2016
Vaginal Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Va...
19 May 2016 by Global Data USD $2,500 More Info
Vaginal Cancer Global Clinical Trials Review, H1, 2016
Vaginal Cancer Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Va...
19 May 2016 by Global Data USD $2,500 More Info
HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020
Increasing awareness of cervical cancer screening programs, and government initiative and funding ar...
12 Feb 2016 by MarketsandMarkets USD $4,650 More Info
Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2015
Postmenopausal Vaginal Atrophy Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical t...
09 Dec 2015 by Global Data USD $2,500 More Info
Soft Tissue Repair Market by Product (Mesh/Tissue patch, Allograft, Xenograft, Suture Anchor, Interference Screws, Laparoscopic Instruments) by Application (Hernia, Dural, Orthopedic, Skin, Dental, Vaginal, Breast augmentation) - Global Forecast to 2019
Soft tissue repair products are used to repair and reconstruct soft tissue injuries. The soft tissue...
06 Mar 2015 by MarketsandMarkets USD $5,650 More Info

This report is published by Global Data

Download Free Report Summary PDF

Vaginal Atrophy (Atrophic Vaginitis) Global Clinical Trials Review, H2, 2015 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...